BioEclipse Therapeutics
CA - Mountain ViewBiotechnology
Focus: BioEclipse Therapeutics is an immuno-oncology focused biotech company headquartered in Mountain View, CA, developing cell and gene therapies for solid tumors. The company is public-stage but pre-revenue with a nascent pipeline.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Total Funding
$70M
Open Jobs
0
About BioEclipse Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow BioEclipse Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CRX100 suspension for infusion
Solid Tumor, AdultClinical Trials (1)
NCT04282044Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Phase 1Help build intelligence for BioEclipse Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.